Insider buying
~$50K50K sh @ $1.01
Traded Nov 17 · filed 2 days later
Since the trade −16.8% · S&P 500 −5.8% · to Nov 20
Bought at the 52-week low, RSI 32, 44% under its 200-day average, 48 points behind the S&P 500 over 3 months
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 1 h ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider buying
Traded Nov 17 · filed 2 days later
Since the trade −16.8% · S&P 500 −5.8% · to Nov 20
Bought at the 52-week low, RSI 32, 44% under its 200-day average, 48 points behind the S&P 500 over 3 months
A Palisade Bio director paid $50K out of pocket for Palisade Bio shares. Shares held went up 11% with this purchase.
Lately at Palisade Bio: it reported its results on Nov 10; the stock is down 40% in 30 days; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Traded Nov 18, 2026 · largest single transaction ~$5.27MNot reported under a pre-arranged trading plan
Lately at CME Group: it reported its results on Oct 21; insiders made no purchase ($10K+) and 6 large sales ($250K+, not pre-arranged) in 90 days.
Nov 18, 2026~$5.27M · 17K sh @ $310.18
DetailsOfficial recordNov 18, 2026~$3.09M · 10K sh @ $308.54
DetailsOfficial recordTraded Sep 23 – Sep 25, 2026 · largest single transaction ~$59K
Lately at Bioaffinity Technologies: it changed its bylaws, charter or fiscal year on Nov 20; the stock is down 54% in 30 days; insiders made 10 purchases ($10K+) and 1 large sale ($250K+, not pre-arranged) in 90 days.
Sep 23, 2026~$59K · 7,509 sh @ $7.91
DetailsOfficial recordSep 25, 2026~$57K · 7,271 sh @ $7.81
DetailsOfficial recordInsider buying
Traded Nov 18 · filed 1 day later
Since the trade −0.3% · S&P 500 −5.5% · to Nov 20
Bought 88% below the 52-week high, RSI 27, 77% under its 200-day average, 73 points behind the S&P 500 over 3 months
The CEO of Maris Tech paid $31K out of pocket for Maris Tech shares.
Lately at Maris Tech: the stock is down 36% in 30 days.
Insider selling
Traded Nov 16 · filed 3 days laterNot reported under a pre-arranged trading plan
Since the trade −3.3% · S&P 500 −6.8% · to Nov 20
A major shareholder of Constellation Brands sold $65.3M of Constellation Brands shares. The filing does not indicate a pre-arranged trading plan.
Lately at Constellation Brands: the stock is up 7% in 30 days; insiders made no purchase ($10K+) and 13 large sales ($250K+, not pre-arranged) in 90 days.
Traded Nov 16, 2026 · largest single transaction ~$21.8MNot reported under a pre-arranged trading plan
Lately at Constellation Brands: the stock is up 7% in 30 days; insiders made no purchase ($10K+) and 13 large sales ($250K+, not pre-arranged) in 90 days.
Nov 16, 2026~$10.9M · 75K sh @ $145.00
DetailsOfficial recordNov 16, 2026~$10.9M · 75K sh @ $145.00
DetailsOfficial recordNov 16, 2026~$21.8M · 150K sh @ $145.00
DetailsOfficial recordNov 16, 2026~$21.8M · 150K sh @ $145.00
DetailsInsider selling
Traded Nov 17 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −6.2% · S&P 500 −5.8% · to Nov 20
A major shareholder of Ibotta sold $21.4M of Ibotta shares. The filing does not indicate a pre-arranged trading plan.
Lately at Ibotta: the stock rose 21% in one session on Nov 3 around a company release; it changed a top executive or board member on Nov 17; the stock is up 9% in 30 days.
Insider buying
Traded Nov 18 · filed 1 day later
Since the trade −8.6% · S&P 500 −5.5% · to Nov 20
Bought 62% below the 52-week high, RSI 25, 21% under its 200-day average, 34 points behind the S&P 500 over 3 months
The CEO of Orion Energy Systems paid $10K out of pocket for Orion Energy Systems shares. 1 other person at Orion Energy Systems bought some too, in the same month.
Lately at Orion Energy Systems: the stock fell 29% in one session on Nov 5 around a company release; it reported its results on Nov 5; the stock is down 49% in 30 days.
Insider buying
Traded Nov 17 · filed 2 days later
Since the trade +0.9% · S&P 500 −5.8% · to Nov 20
Bought within 4% of the 52-week low, RSI 25, 59% under its 200-day average, 54 points behind the S&P 500 over 3 months
Novabridge Biosciences's Chief Commercial Officer paid $16K out of pocket for Novabridge Biosciences shares. It was the first purchase in 7 months. Shares held went up 20% with this purchase.
Lately at Novabridge Biosciences: the stock is down 39% in 30 days.
Insider selling
Traded Nov 19 · filed the same day
A major shareholder of Fermi told the SEC about a plan to sell $5.15M of Fermi shares around Nov 19, 2026. The shares were not acquired as compensation. That is 0.4% of all Fermi shares.
Lately at Fermi: the stock rose 27% in one session on Nov 13 around a company release; it reported its results on Nov 12; the stock is down 32% in 30 days.
Insider buying
Traded Nov 18 · filed 1 day later
Since the trade −11.1% · S&P 500 −5.5% · to Nov 20
Bought within 3% of the 52-week low, RSI 32, 61% under its 200-day average, 37 points behind the S&P 500 over 3 months
The CEO of Lument Finance Trust paid $10K out of pocket for Lument Finance Trust shares. 1 other person at Lument Finance Trust bought some too, in the same month.
Lately at Lument Finance Trust: the stock fell 15% in one session on Nov 13 with press coverage; it reported its results on Nov 16; the stock is down 24% in 30 days.
Insider selling
Traded Nov 16 · filed 3 days laterNot reported under a pre-arranged trading plan
Since the trade −3.3% · S&P 500 −6.8% · to Nov 20
A Constellation Brands director sold $21.8M of Constellation Brands shares. The filing does not indicate a pre-arranged trading plan.
Lately at Constellation Brands: the stock is up 7% in 30 days; insiders made no purchase ($10K+) and 13 large sales ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 18 · filed 1 day later
Since the trade −6.9% · S&P 500 −5.5% · to Nov 20
Bought at the 52-week low, RSI 40, 21% under its 200-day average, 15 points behind the S&P 500 over 3 months
A major shareholder of Joint paid $69K out of pocket for Joint shares.
Lately at Joint: it reported its results on Nov 5; the stock is down 14% in 30 days; insiders made 5 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 18 · filed 1 day later
Since the trade −0.3% · S&P 500 −5.5% · to Nov 20
Bought 41% below the 52-week high, RSI 23, 13% above its 200-day average, 17 points behind the S&P 500 over 3 months
The CEO of Atlassian paid $28K out of pocket for Atlassian shares.
Lately at Atlassian: the stock fell 16% in one session on Nov 6 around a company release; it changed a top executive or board member on Nov 5; the stock is down 40% in 30 days.
Insider buying
Traded Nov 17 · filed 2 days later
Since the trade −12.0% · S&P 500 −5.8% · to Nov 20
Bought 32% below the 52-week high, RSI 29, 13% under its 200-day average, 14 points behind the S&P 500 over 3 months
The CEO of Agora paid $26K out of pocket for Agora shares.
Lately at Agora: the stock fell 10% in one session on Nov 17 with press coverage; the stock is down 30% in 30 days; insiders made 44 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.